Accretive Health prices public offering of 6,500,000 shares of common stock

Accretive Health, Inc. (NYSE:AH), a leading provider of services that help healthcare providers generate sustainable improvements in their operating margins and healthcare quality while also improving patient, physician and staff satisfaction, today announced the pricing of the public offering of 6,500,000 shares of its common stock at a price to the public of $23.50 per share. All of the shares are being offered by selling stockholders. In addition, the underwriters have a 30-day option to purchase up to an additional 975,000 shares from the selling stockholders. The company will not receive any proceeds from the sale of shares in this offering.

Goldman, Sachs & Co., Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC are joint book runners for the offering. Robert W. Baird & Co. Incorporated is acting as co-manager of the offering.

A registration statement relating to this offering was filed with and declared effective by the U.S. Securities and Exchange Commission. This offering was made solely by means of a prospectus. A copy of the prospectus relating to this offering may be obtained from Goldman, Sachs & Co., 200 West Street, New York, New York 10282-2198, Attention: Prospectus Department, telephone (866) 471-2526; Credit Suisse Securities (USA) LLC, Madison Avenue, New York, New York 10010, Attention: Prospectus Department, telephone (800) 221-1037; or from J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone (866) 803-9204.